Annual Retained Earnings
-$58.50 M
-$16.12 M-38.04%
December 31, 2023
Summary
- As of February 12, 2025, CTCX annual retained earnings is -$58.50 million, with the most recent change of -$16.12 million (-38.04%) on December 31, 2023.
- During the last 3 years, CTCX annual retained earnings has fallen by -$25.73 million (-78.50%).
- CTCX annual retained earnings is now -78.50% below its all-time high of -$32.77 million, reached on December 31, 2021.
Performance
CTCX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$67.96 M
-$2.88 M-4.42%
September 30, 2024
Summary
- As of February 12, 2025, CTCX quarterly retained earnings is -$67.96 million, with the most recent change of -$2.88 million (-4.42%) on September 30, 2024.
- Over the past year, CTCX quarterly retained earnings has dropped by -$6.30 million (-10.21%).
- CTCX quarterly retained earnings is now -2728.14% below its all-time high of -$2.40 million, reached on June 30, 2023.
Performance
CTCX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CTCX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.0% | -10.2% |
| 3 y3 years | -78.5% | -60.3% |
| 5 y5 years | -78.5% | -60.3% |
CTCX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.5% | at low | -2728.1% | at low |
| 5 y | 5-year | -78.5% | at low | -2728.1% | at low |
| alltime | all time | -78.5% | at low | -2728.1% | at low |
Carmell Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$67.96 M(+4.4%) |
| Jun 2024 | - | -$65.08 M(+5.3%) |
| Mar 2024 | - | -$61.77 M(+5.6%) |
| Dec 2023 | -$58.50 M | -$58.50 M(-5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$61.66 M(+2466.1%) |
| Jun 2023 | - | -$2.40 M(-94.3%) |
| Dec 2022 | -$42.38 M(+29.3%) | -$42.38 M |
| Dec 2021 | -$32.77 M | - |
FAQ
- What is Carmell Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Carmell Therapeutics?
- What is Carmell Therapeutics annual retained earnings year-on-year change?
- What is Carmell Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly retained earnings year-on-year change?
What is Carmell Therapeutics annual retained earnings?
The current annual retained earnings of CTCX is -$58.50 M
What is the all time high annual retained earnings for Carmell Therapeutics?
Carmell Therapeutics all-time high annual retained earnings is -$32.77 M
What is Carmell Therapeutics annual retained earnings year-on-year change?
Over the past year, CTCX annual retained earnings has changed by -$16.12 M (-38.04%)
What is Carmell Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CTCX is -$67.96 M
What is the all time high quarterly retained earnings for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly retained earnings is -$2.40 M
What is Carmell Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CTCX quarterly retained earnings has changed by -$6.30 M (-10.21%)